https://www.mdanderson.org/cancerwise/second-generation-inhibitors-may-change-prognosis-for-patients-with-FLT3-positive-acute-myeloid-leukemia-AML.h00-159466368.html
When driven by the FLT3 mutation, acute myeloid leukemia is more likely to recur. Naval Daver, M.D., shares how new therapeutic combinations and...
acute myeloid leukemiamd andersongilteritinibtreatpositive